OVERVIEW

American Society of Anesthesiologists (ASA) Journal CME is organized by American Society of Anesthesiologists (ASA) and will be held during Aug 15, 2017 - Aug 14, 2020.

The target audience for this medical event is ANESTHESIOLOGY Journal CME is intended for anesthesiologists. Researchers and other health care professionals with an interest in anesthesiology may also participate. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.

Preoperative administration of the antifibrinolytic agent tranexamic acid reduces bleeding in patients undergoing hip arthroplasty. Increased fibrinolytic activity is maintained throughout the first day postoperation. The objective of the study was to determine whether additional perioperative administration of tranexamic acid would further reduce blood loss. This prospective, double-blind, parallel-arm, randomized, superiority study was conducted in 168 patients undergoing unilateral primary hip arthroplasty. Patients received a preoperative intravenous bolus of 1 g of tranexamic acid followed by a continuous infusion of either tranexamic acid 1 g (bolus-plus-infusion group) or placebo (bolus group) for 8 h. The primary outcome was calculated perioperative blood loss up to day 5. Erythrocyte transfusion was implemented according to a restrictive transfusion trigger strategy.

Conference Objectives are :

After successfully completing this activity, the learner will be able to:
• Inform patients of the benefits of using tranexamic acid (TXA) to reduce blood loss (1, 3) • Determine the best method of TXA administration for a specific patient during hip surgery (4, 5, 6) • Advise the patient on the risks associated with the use of TXA (2, 3, 4, 5)

Additional details will be posted as soon as they are available.